Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis

Ceftazidime-avibactam (CZA) is a novel beta-lactam beta-lactamase inhibitor combination approved for the treatment of complicated urinary tract infections, complicated intra-abdominal infections, and for hospital-acquired/ventilator-associated pneumonia. The aim of this systematic review (PROSPERO r...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiore, Marco, Alfieri, Aniello, Di Franco, Sveva, Pace, Maria Caterina, Simeon, Vittorio, Ingoglia, Giulia, Cortegiani, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400227/
https://www.ncbi.nlm.nih.gov/pubmed/32645986
http://dx.doi.org/10.3390/antibiotics9070388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400227/
https://www.ncbi.nlm.nih.gov/pubmed/32645986
http://dx.doi.org/10.3390/antibiotics9070388

Ejemplares similares